DETAILED PRODUCT SEARCH

PRODUCT NAME

PRODUCT TYPE

FORM

PRODUCT ACTIVE INGREDIENT

COMMERCIAL SHAPE

SORT

Our Products

Nanogam

Nanogam

Form(%5) 2.5g/50 ml, 5g/100 ml, 10g/200 ml - (%10) 2.5g/25 ml, 5g/50 ml, 10g/100 ml, 20g/200 ml, 30 g/300 ml Solution for IV infusion

ACTIVE INGREDIENTHuman normal immunoglobulin

COMMERCIAL SHAPE1 vial/box

Therapeutic Indications:

1. For replacement therapy in immunodeficiency conditions;

a) In primary (congenital) immune deficiencies where antibody production is impaired

b) In patients with chronic lymphocytic leukemia and hypogammaglobulinemia, for whom prophylactic antibiotics are inadequate and recurrent bacterial infections develop,

c) In cases with multiple myeloma diagnosed with hypogammaglobulinemia and recurrent bacterial infection, where pneumococcal immunization is inadequate

d) In children and adolescents with congenital AIDS and recurrent infections

e) In cases with hypogammaglobulinemia after allogenic hematopoietic stem cell transplantation

 

2. For the immunomodulatory effect;

a) In patients with immune thrombocytopenia (ITP) who have a high risk of bleeding or need to increase their platelet count before surgical intervention

b) In Guillain-Barre syndrome,

c) In Kawasaki disease

d) Multifocal Motor Neuropathy (MMN) disease

e) In the acute treatment of Chronic Inflammatory Demyelinising Polineuropathy (CIDP)

f) In the treatment of Myasthenia Gravis with bulbar involvement

EUGMP
BBS